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Materials and Methods: This practice changing study was 
done in two phases. In phase 1, 17 women prescribed to 
curative radiotherapy for rectal or anal cancer were asked to 
complete a simple questionnaire about the vaginal dilator 
therapy at a routine follow-up after their radiotherapy 
course. Our findings led to modification of our clinical 
practice such as written patient information, increased 
clinician and nursing skills as well as improved patient-nurse 
communication. In phase 2, 25 new women were enrolled in 
a repeat study with an updated questionnaire. This assessed 
the effects of the changes in our clinical practice. The 
answers were transcribed in to an electronic survey system, 
to ensure correct data analysis. 
Results: All 43 women completed the questionnaire. In phase 
1, we excluded 1/17 that did not receive a dilator. 1/16 did 
not use the dilator due to having regular intercourse and 
6/16 women regularly used a dilator 1-2 times a week. In 
phase 2, 80 % of women felt well informed about reasons and 
outcomes of using a dilator. We excluded 1/25 women that 
did not receive a dilator. 5/24 women did not use the dilator 
due to having regular intercourse and 11/24 regularly used a 
dilator 1-2 times per week. The proportion of women 
regularly using a dilator was not statistically different 
between the two groups. A larger proportion of women 8/11 
(73 %), used a specific dilator compared to 3/13 (23%) with 
other types of dilator (p < 0.05). 
 
Conclusions: Phase 1 results showed that clinical practice 
was neither sufficient nor satisfactory. Modifying clinical 
practice, led to more women regularly using a dilator at the 
time of check up, but was not statistically significant due to 
at small study size. Focusing patient information on the 
importance of regular intercourse, rather than dilator use, 
appeared to have increased the reported frequency of 
woman having a regular sex life. Besides regular intercourse, 
major reasons for lack of dilator use were pain, 
anxiety/discomfort and misinformation. Current results 
suggest (i) structured nursing interventions may be required 
to control pain, (ii) nurses have an essential role in explaining 
dilator use and addressing feelings of anxiety/discomfort, 
(iii) further refinement to our patient information procedure 
is needed because misinformed women only used a dilator for 
a short period after radiotherapy, (iv) women do appear to 
show preference for using a particular dilator type. 
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Purpose/Objective: The improvement of public knowledge of 
radiotherapy is a global objective; specifically we believe 
that if patients have a more thorough understanding of the 
processes and issues then they may be more compliant to 
preparatory instructions and have reduced anxiety regarding 
treatment. Information is often more efficiently absorbed 
when presented in a novel manner, in this study we utilised a 
computer simulation of a Linear Accelerator. 
Materials and Methods: PEARL is a commercially available PC 
based tool that provides a realistic and functional 3D model 
of a Linear Accelerator and, using a DICOM interface, can 
visualise treatment plans. We staged 'drop-in' sessions in the 
waiting room of our clinic. Patients, that were under 
treatment and their carers, were offered demonstrations and 
explanations of the treatment process by two treatment 
radiographers (RTTs) using PEARL; no specific treatment site 
was targeted. Immediately following the discussion, 
comments were invited and captured using a 'free text' 
questionnaire. Post processing split these responses into 
common themes and where appropriate, multiple comments 
were scored per patient. 
Results: Over three sessions 116 patients viewed the 
demonstration and 64 patients (or carers) returned feedback; 
139 individual comments were identified in the post 
processing of the free text written responses. In general the 
recorded comments were all positive and reflected that the 
use of the computer simulation tool had been useful in 
communicating the information imparted. After reviewing 
the responses, 5 common themes emerged from the recorded 
comments: 1) 'around patient expectations' (24 comments 
recorded, of these 12 recorded it helped reduce anxiety); 2) 
'demonstration was helpful and informative' (43 comments 
recorded, of these 6 related to carers); 3) 'understanding the 
need for compliance in bladder and bowel preparation' (6 
comments recorded); 4) 'around understanding the 
technology' (25 comments recorded); and 5) 'recommendation 
regarding the timing of information delivery' (41 comments 
recorded, of these 35 stated they would have preferred to 
have seen PEARL before their treatment commenced). 48% of 
the patients were prostate patients and many gave verbal 
comments as to the usefulness in understanding their bowel 
and bladder preparation instructions although not all left 
written feedback. 
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Conclusions: The information sessions, using the PEARL 
software, were popular with our patients. This pilot study has 
served to help plan a further study wherein the session will 
be staged, post CT planning, but prior to treatment. In turn 
this will act as a pilot to produce evidence to support an 
intended randomised study to test the hypothesis that 
appropriate information given via this graphical interface will 
promote greater compliance with prostate patients and result 
in fewer 'on treatment' interventions. 
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Purpose/Objective: Use of three-dimensional (3D) virtual 
reality (VR) technology in patient information is a novel tool 
in radiotherapy (RT). Results from a pilot project on using 3D 
VR technology in the information to patients and relatives 
showed that all participants (n=89) in six ‘Open house’ 
sessions reported that VR was useful in the understanding of 
RT. A total of 97% replied they had found answers to 
questions they had been contemplating during the course of 
their treatment. Several patients expressed a wish to get 
their own treatment plan presented in 3D. The aim of this 
study was to test if showing patients their own RT dose plan 
in 3D would increase their knowledge of and confidence in RT 
treatment.  
Materials and Methods: All patients (n=58) with cancer in the 
pelvic area starting curative RT during a period of 2½ months 
were offered a presentation of their own dose plan using 3D 
VR technology (VERTUAL Ltd.). Relatives were invited to 
participate. Oral and written information about RT 
supplemented with information on DVD, had been given 
previously. Before the 3D presentation, participants filled in 
a questionnaire including questions about confidence and 
knowledge about the target of RT, CT-scans and dose 
planning, positioning and dose delivery, possible side effects 
and causes of side effects. After the VR presentation the 
participants evaluated the same topics again with focus on 
level of confidence, amount of new knowledge and 
importance of the new knowledge; it was possible to 
supplement with comments. The patient filled in the 
questionnaire in collaboration with the project manager. 
Results: Response was obtained from 32 of 58 included 
patients (58%); Average age was 64 years (38-79). Number of 
completed fractions at time of VR session was 9 on average 
(range 3-36). Relatives participated in almost half of the 
presentation sessions (n=15). A total of 41% of the 
participants reported a higher level of confidence in the RT 
treatment after the presentation; none reported a lower 
level. Figure 1 shows amount of new knowledge and the 
importance of the new knowledge according to patients. Both 
patients and relatives evaluated the presentations as 
informative and relevant; statements included: 'It’s 
important to see my own dose plan, this clarifies organs 
being radiated and how healthy tissue can be spared', and 
'I’ve got a better understanding of what’s going on with my 
husband'. 
 
Conclusions: It seems that presentation of patients own dose 
plan in 3D VR gives a visual understanding for most patients. 
A high number of patients reported they received important 
new knowledge about target definition, planning of 
treatment, positioning, possible side effects and causes of 
side effects.  
The presentations also lead to increased confidence about 
RT. The 3D VR technique makes it easier for patients and 
relatives to understand a high-technology treatment and can 
be used as supplement to inform about RT. 
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Purpose/Objective: The Department of Health (DH) state 
that access to appropriate and timely radiotherapy (RT) 
services, including modern techniques such as Intensity-
Modulated Radiotherapy (IMRT) and Image-Guided 
Radiotherapy (IGRT), is crucial in improving outcomes for 
cancer patients. It has been estimated that current UK 
services will be inadequate to treat future populations in a 
timely and effective manner, and that more investment is 
needed for RT provision. The National Radiotherapy Advisory 
Group (NRAG) recommended commissioning of more fractions 
to combat increasing demand in an ageing UK population. 
Commissioners recognise that workload and factors affecting 
efficiency need to be addressed, however few studies 
consider the daily demand of a linear accelerator. There is a 
lack of ‘real-time’ data regarding the impact of increasingly 
complex techniques on treatment times and whether current 
scheduling is reflective of time needed for RT delivery. 
Materials and Methods: A systematic quantitative process 
evaluation was undertaken in a large regional cancer centre, 
including a satellite centre, between January and April 2014. 
